Advanced Biomed Inc. (ADVB) stock

ADVBNasdaqServices-Medical LaboratoriesFiscal year ends June 30

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30

$2.53−0.78 (-23.56%)

Close on Nov 13, 2026Market cap $4.18MP/E 0.4Yield –

Advanced Biomed ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was -$742.64K.

Period	Period end	Value	Change
FY2025	Jun 30, 2025	-$742.64K	–

Change is against the same quarter a year earlier.

Periods

Period	Period end	Value	Change
Q1 FY2026CQ3 2025	Sep 30, 2025	-$99.16K	–

Parsed from the XBRL in Advanced Biomed's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-20 reverse split on Feb 20, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ADVB.

Operating margin-4883.8% · median -10789.2%

Net margin4759.5% · median -10260.0%

Advertisement
300 × 250

See a number that looks wrong?